In this seminar, Sam Behjati, Group Leader at the Wellcome Sanger Institute, will provide an overview of how high-throughput single-cell mRNA-seq technologies have helped to understand the origin of childhood cancer and the novel treatments researchers can derive from these insights.
- Share your Experience
GenomeWebUSA115 Total Events / 1 Upcoming Event
More Events From The Organizer
- Configuring R&D Experiments an..19 Jul 2021Online